Atlas Trials

Berberine Improving Cognitive Impairments in Schizophrenia

Clinical trial NCT07359209 · COMPLETED

Trial details

NCT number
NCT07359209
Sponsor
Tianjin Anding Hospital
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Schizophrenia Therapeutics
Start date
2023-07-21
Primary completion
2026-01-30
Enrollment
124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.